Viroclinics Biosciences completed the acquisition of DDL Diagnostic Laboratory.

Summit Partners-backed Viroclinics Biosciences, a virology contract research organization, completed the acquisition of DDL Diagnostic Laboratory, a diagnostic solutions provider. Financial terms were not disclosed. "By joining with DDL, we will enhance Viroclinics' leading position as a specialized contract research organization, adding to our service offering, capacity and geographic presence," Bob van Gemen, Viroclinics Biosciences CEO.